Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.
Hip Prosthesis
Bile Duct Neoplasms
Neural Conduction
Subsite specificity of anthrax lethal factor and its implications for inhibitor development.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Subsite specificity of anthrax lethal factor and its implications for inhibitor development.
Subsite specificity of anthrax lethal factor and its implications for inhibitor development. Biochem Biophys Res Commun. 2011 Apr 08; 407(2):400-5.
View in:
PubMed
subject areas
Anti-Bacterial Agents
Antigens, Bacterial
Bacterial Toxins
Drug Design
Hydrophobic and Hydrophilic Interactions
Protease Inhibitors
Substrate Specificity
authors with profiles
Feng Li